RecallGuide.ca
    Health productsUpdated Jan 3, 2026Atoma, Option+, Rexall Corp, Biomedic, LD, Pharmasave, Co-op Care +, Compliments, Health One, Personnelle, LBOfficial source

    Acid Reducer (Ranitidine) recall in Canada: contamination risk

    Share:

    In plain language

    This recall involves various brands of Acid Reducer (Ranitidine) tablets sold in Canada. They are being recalled because they contain an N-nitrosodimethylamine (NDMA) impurity above acceptable limits. Consult your healthcare provider before stopping use and follow the return steps in the official notice.

    What to do

    • Verify if your product is affected.
    • Consult your healthcare provider prior to discontinuing use.
    • Contact the recalling firm if you have questions.
    • Report any health product related side effects to Health Canada.

    Get alerts for recalls like this

    Get email alerts when new recalls affect products in this category.

    Categories (optional)

    No spam. Unsubscribe anytime. We only email when there's a relevant recall.

    Affected products

    • ATOMA-ACID RED MAX F 150mg C ALV 3X8

      Lot: 627765H

    • OPTION+ REDUC ACIDE 75mg COMP ALV 1x10

      Lot: 632952B

    • OPTION+ REDUC ACIDE 75mg COMP ALV 4X10

      Lot: 633694B

    • Option+ REDUC ACID F MAX 150mg CO ALV3X8

      Lot: 627765G

    • Option+ REDUC ACID F MAX 150mg CO AL 1X8

      Lot: 627765B

    • Rexall Corp-REDUC ACIDE 150mg CO ALV 3X8

      Lot: 627765F

    • Rexall Corp-REDUC ACIDE 150mg CO ALV 1X8

      Lot: 627765A

    • BIOMEDIC REDUC ACIDE 75mg COMP ALV 3X10

      Lot: 632952I

    • BIOMEDIC-ACID RED F MAX 150mg COM ALV3X8

      Lot: 627765I, 628471C

    • LD-REDUC ACIDE F MAX 150mg COMP ALV 3X8

      Lot: 627765E

    • PHARMASAVE-RED ACID F MAX 150mg CO AL1X8

      Lot: 627765C

    • PHARMASAVE-RED ACID F MAX 150mg C ALV3X8

      Lot: 628471B

    • CO-OP CARE + ACID REDU F M 150mg C AL3X8

      Lot: 627765D

    • Compliments-REDUC ACIDE 150mg C ALV 3X8

      Lot: 628471D

    • Health One-REDUC ACIDE 150mg COM ALV 4X8

      Lot: 628471A

    • Personnelle-REDUC ACIDE 75mg CO ALV1X10

      Lot: 632952D

    • LB-REDUC D'ACIDE 75mg COMP ALV 3X10

      Lot: 632952K

    Why this matters

    Contamination

    Do I have this product?

    This recall only applies to specific products. Follow the steps below to check.

    1. 1

      Check the product name

      Make sure your product name matches one of the affected products listed above.

    2. 2

      Check the lot number

      Lot numbers identify specific production batches.

      Affected lots: 627765A, 627765B, 627765C, 627765D, 627765E, 627765F, 627765G, 627765H, 627765I, 628471A, 628471B, 628471C, 628471D, 632952B, 632952D, 632952I, 632952K, 633694B

    If your product matches one or more of the details above, it may be affected by this recall.

    If your product does not match these details, it is not affected by this recall.

    When in doubt, always check the official notice.

    Want alerts if similar products are recalled in Canada?

    Frequently Asked Questions

    Why was this product recalled?

    Contamination

    What should consumers do?

    Verify if your product is affected. Consult your healthcare provider prior to discontinuing use. Contact the recalling firm if you have questions. Report any health product related side effects to Health Canada.

    Where was the product sold?

    This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.

    Is there a health risk?

    Yes, there may be a health risk. Contamination

    When was this product recalled?

    This product was recalled on December 3, 2021.

    Is the Atoma, Option+, Rexall Corp, Biomedic, LD, Pharmasave, Co-op Care +, Compliments, Health One, Personnelle, LB brand affected by this recall?

    Yes, Atoma, Option+, Rexall Corp, Biomedic, LD, Pharmasave, Co-op Care +, Compliments, Health One, Personnelle, LB products are affected by this recall. This recall involves various brands of Acid Reducer (Ranitidine) tablets sold in Canada. They are being recalled because they contain an N-nitrosodimethylamine (NDMA) impurity above acceptable limits. Consult your healthcare provider before stopping use and follow the return steps in the official notice.